Poly-Analyte Cancer Test

PACT is a poly-analyte diagnostic platform that combines biosensing and artificial intelligence. The biosensor measures the expression of proteins and microRNAs in peripheral blood without the requirements of amplification or sequencing. Then, a proprietary algorithm analyzes the expression of the biomarkers to deliver the diagnostic. This combination results in an accurate biomarker selection and an easy to use detection method providing a unique diagnostic test for seven types of cancer. After the FDA approval, the PACT platform will be sold to hospitals, clinics, and laboratories. PACT Platform can detect many pre-assembled panels of biomarkers, opening possibilities for secondary diagnostic solutions.

  • Facebook Social Icon
  • https://www.linkedin.com/in/conquerx
Boston, USA
UMass-Boston, Wheatley Hall, 3rd Floor
100 Morrissey Boulevard, Boston MA 02125 USA
Cambridge, UK
Unit 6 Queens Yard, London, E9 5EN, United Kingdom.

This project has received funding from the European Union's Horizon 2020 SME Instrument program under grant agreement nr 854871

©2018 ConquerX. All rights reserved